Individually identifiable genetic information (human subject identifiable).

Formerly: Sensitive Identifiable Human Subject Research

Research that obtains or accesses individually identifiable private information about humans through interactions or interventions with the individual (known as human subject research) requires protections against unauthorized access. Private identifiable information includes medical records, education records, and any other information that an individual  believes  is private. 

IRB Review Process

The UC Davis IRB reviews research involving human subjects to ensure (1) there are adequate protections for the study participants; and (2) the research is compliant with UC Davis standard operating procedures and applicable regulations and guidance. In some instances, the UC Davis IRB will allow an external IRB to review research conducted at UC Davis. During the review, the IRB is required to determine whether the study participants’ privacy and confidentiality are protected. The IRB will review the protocol to see if this requirement is met, so the protocol must clearly describe how the research will protect data about the participant from unauthorized access or disclosure. The level of protection required depends upon the sensitivity of the information being accessed or created during the research.

In many instances, the IRB will determine that the risk of inadvertent access or disclosure can be minimized if the protocol required data to be accessed or created in a de-identified or anonymous format.   

  • De-identified means the data are stripped of all identifying information (names, dates relating to the individual, account numbers, phone numbers, email addresses, etc.) and coded. The code can be linked to the individual’s identity but the key to the code is usually held by a third party, often referred to as the “honest broker.” 
  • Anonymous means the data are stripped of all identifiers and link to the participants’ identity is maintained.   

If the research cannot be conducted unless the data accessed or created are identifiable, the IRB will look at the sensitivity of the data and whether the information is confidential or private.   

  • Sensitive information includes information about health, grades, mental status, sexual preferences, substance abuse, personal finances, etc.
  • Confidential information is secret, meaning there are laws or agreements that prohibit the information from use and/or disclosure without meeting specific requirements such as consent from the individual.  See Privacy Laws below.  
  • Private information is information that an individual does not believe would be made public such as emails, texts, other correspondence, or their location (GPS coordinates) at specific times.  

If the identifiable data include information that is sensitive, confidential or private, then the IRB will require the data to be maintained in a secure manner and will require protections such as data encryption, use of authentication mechanisms such as user names and passwords, audit trails, staff training, etc. The IRB works with the Information Security Office and Privacy Officer to determine whether security measures are adequate.  For more information about data security, contact [someone from information security].  Click here for more information about the IRB submission process.

Laws/Regulations/Policies

Health Human Services Human Subjects website

Federal Policy for the Protection of Human Subjects or Common Rule

FDA Regulations for IRBs

Health Information and Portability Act (HIPAA) Privacy Rule and Security Rule

Family Educational Rights and Privacy Act (FERPA)

Protection of Pupil Rights Amendment

FDA Regulations for Information Consent and Protections for Children

Additional Resources

IRB Regulations, Policies, and Guidance

UC Davis Human Research Protection Program

UC Davis Research Compliance - Human Subject Research

Examples

The National Institutes of Health (NIH) defines “sensitive information” as information relating to:

  • Illegal behaviors
  • Drug or alcohol abuse
  • Sexual behavior
  • Mental health or other sensitive health or genetic information
Contact Info
Ben (Benjamin) Mooso
Interim Director, IRB
916-703-9164
+1 916 703 9164
NOTE: Ben is the Interim Director as of December 2018. This may change in the future once a new permanent IRB Director is hired.
Protection Level
P4

Allowed Services

- No Services Found -

Disallowed Services

- No Services Found -

Seek Guidance for Services

- No Services Found -
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content
  • Dummy Content